Advanced Technologies and Products for a higher quality of life.
In order to fulfill our mission, to bring science to people to improve their quality of life, Neuroinnovation Ltd. has been developing new products and technology based in cutting-edge scientific research. They are related to prevention and early diagnosis of neurodegenerative impairments which at this point are at different stages of development.
At present, the following are the products and technology already developed by our company, which are in process of patenting or commercialization:
Is a nutraceutical dietary supplement that blends the high antioxidant activity of the “Andean Compound”, which is a natural phytocomplex obtained and purified from old organic deposits, with the neuroprotector effects of Vitamines B12, B6, and B9, (Folic Acid).
This product of high standard and innovation is based in solid scientific studies, publications and conclusive clinic assays. The “Andean Compound” is an organic material very rich mainly in humic substances, Fulvic Acid and selenium, which exhibit antiaging properties and also help to modulate the energetic balance in humans. The clinical evidence point out to its pro-cognitive actions, and is highly recommended to prevent cognitive disorders such as AD and other dementia.
As a scientific group we think, this is a very significant contribution in the prevention of the cognitive damage in humans.
More information can be found in www.brainup-10.cl
This product is a software of cognitive stimulation developed in our laboratories, which main purpose is to prevent, detain or delay the initial cognitive damage in humans produce by trauma reasons or cognitive disorders or illness.
comes in a “pendrive” very easy to use. Designed to work in 6 brain cognitive areas: memory, language, attention, calculus, gnosias and orientation. Each activity has 12 levels of difficulties which adapt automatically to the user’s capacities. This software of more tnan 4800 exercises, can be used by normal people as well as for people with some degree of cognitive impairment, stimulating mental activity, working specific brain functions looking to keep or expand its capacities.
This software was developed in collaboration with ADEXUS S.A. a company specialized in informatic systems and software.
More information can be found in www.activamente.cl
Alz-tau® is an innovative and advanced detection method for Alzheimer’s disease, based on the detection of pathogenic tau protein variants (a hallmark in AD) as a molecular biomarker. This technology consists in a non-invasive platelet diagnosis procedure for early detection of AD.
This method has been developed in our labs as a highly sensitive, efficient and reliable test for early diagnose of AD, with just a blood sample. Also used for the differential diagnosis of AD.
Our patented technology is highly innovative because it is based on a high impact scientific discovery from our laboratory. Alz-tau® discovery has been clinically validated, and recognized by the scientific and medical community, being highlighted by the Journal of Alzheimer’s Disease (JAD) as one of the most important contribution to this field in 2016.
PET Neuroimages Technology
Developed to detect early neurodegenerative impairments in images. This tool is being developed in our Labs and its based in relevant discoveries of great scientific impact done by a selected group of our scientists. In a near future, this technology will be available to millions of persons, at this point 35.6 million throughout the world. This technology is focused in getting a precise early neurological diagnosis of patients.
These Quinolines have special anti-Alzheimer properties, and has a potential use as a drug for patients with a moderate AD level. This is still in the research process and clinical trials.
With several products under Patenting and Commercialization phases, our Labs continue developing scientific research and new technologies, with high medical standards, trails with approval of ethics committees. So, Neuroinnovation Ltd. brings private business to science to benefit the whole society, taking advantage of the innovation process.